Enabling Technologies for Homing and Engraftment of Cells for Therapeutic Applications

JACC: Cardiovascular Interventions

Volumn 2, Issue 8, 2009, Pages 803-804

  Singh, Jai Pal ^a  

^a Saint Joseph's Translational Research Institute   (United States)

Author keywords

cell homing; cell therapy; heart disease; nanoparticles

Indexed keywords

ESTROGEN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRIC OXIDE DONOR; PROTEIN KINASE B; STROMAL CELL DERIVED FACTOR 1; SUPERPARAMAGNETIC IRON OXIDE; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE;

ANGIOGENESIS; CELL ADHESION; CELL HOMING; CELL MIGRATION; CELL PROLIFERATION; CELL SPREADING; CELL STIMULATION; CELL THERAPY; CLINICAL TRIAL; CONVALESCENCE; DISEASE MODEL; EDITORIAL; ENGRAFTMENT; GENETIC ENGINEERING; HEART FAILURE; HEART FUNCTION; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HUMAN; MAGNETIC STIMULATION; MESENCHYMAL STEM CELL; MYOBLAST; PATIENT SAFETY; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL TRANSPLANTATION; TECHNOLOGY; TREATMENT OUTCOME;

ANIMALS; APOPTOSIS; CELL DIFFERENTIATION; CELL MOVEMENT; CELL SURVIVAL; ENDOTHELIAL CELLS; FERROSOFERRIC OXIDE; HEART DISEASES; HUMANS; MAGNETICS; NANOPARTICLES; STAINING AND LABELING; STEM CELL TRANSPLANTATION; TIME FACTORS;

EID: 68849119882     PISSN: 19368798     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcin.2009.06.009     Document Type: Editorial

References (9)

1. Van der Bogt K.E.A., Sheikh A.Y., Schrepfer S., et al. Comparison of different adult stem cell types for the treatment of myocardial ischemia. Circ 118 (2008) s121-s128
2. Reffelmann T., Könemann S., and Kloner R.A.P.o.b.-b.m.-d.s.c.t.f.f.c.repair. Putting it in perspective with existing therapy. J Am Coll Cardiol 53 (2009) 305-308
3. Li S.H., Lai T.Y., Sun Z., et al. Tracking cardiac engraftment and distribution of implanted bone marrow cells: comparing intra-aortic, intravenous, and intramyocardial delivery. J Thorac Cardiovasc Surg 137 (2009) 1225-1233
4. Dimmeler S., and Leri A. Aging and disease as modifier of efficacy of cell therapy. Circ Res 102 (2008) 1319-1330
5. Werner N., and Nickenig G. Influence of cardiovascular risk factors on endothelial progenitor cells. Limitation for therapy. Arterioscler Thromb Vasc Biol 26 (2006) 257-266
6. Ghani U., Shuaib A., Nasir A., et al. Endothelial progenitor cells during cerebrovascular disease. Stroke 36 (2006) 151-153
7. Chavakis E., Urbich C., and Dimmeler S. Homing and engraftment of progenitor cells: a prerequisite for cell therapy. J Mol Cell Cardiol 454 (2008) 514-522
8. Romagnani P., Lasagni L., Mazzinghi B., et al. Pharmacological modulation of stem cell function. Curr Med Chem 14 (2007) 1129-1139
9. Krytatos P.G., Lehtolsinen P., Junemann-Ramirez M., et al. Magnetic tagging increases delivery of circulating progenitors in vascular injury. J Am Coll Cardiol Intv 2 (2009) 794-802